The spice controversy involving Indian companies MDH and Everest has expanded to include Australia, with Food Standards Australia New Zealand (FSANZ) initiating investigations into potential contamination in spice mixes. Following similar actions taken by Hong Kong and Singapore, Australian authorities are closely monitoring the situation and collaborating with international agencies to assess the need for a recall.
Recent developments have seen Hong Kong suspend the sale of three MDH spice blends and one Everest mix designated for fish curry, while Singapore has issued a recall for the Everest mix due to elevated levels of ethylene oxide, a substance associated with cancer risks upon prolonged exposure.
FSANZ released a statement affirming its engagement with global counterparts to grasp the severity of the issue and is coordinating efforts with federal, state, and territory food enforcement agencies within Australia. The use of ethylene oxide as a food treatment is prohibited in Australia, potentially warranting a recall of affected products pending further investigation.
Both MDH and Everest, renowned spice brands in India, have a widespread presence across Europe, Asia, and North America. The scrutiny has extended beyond borders, with the United States Food and Drug Administration (FDA) also delving into the matter, alongside inspections conducted by Indian authorities at the production facilities of both companies.
This heightened scrutiny underscores the importance of food safety standards, prompting international regulatory responses to mitigate potential health hazards. Australian consumers are urged to remain vigilant and stay abreast of any recalls, prioritizing the safety of their food purchases as the investigation progresses.